🇺🇸 FDA

Intelligence · Clinical Pipeline

Phase I Pipeline Programs

First-in-human and early clinical safety studies in Phase I.

Programs
4,713

Quick answer

NovaPharmaNews tracks 4,713 phase i pharmaceutical pipeline programs from ClinicalTrials.gov. First-in-human and early clinical safety studies in Phase I.

Top sponsors

Page 83 of 99

  1. TAK-935 Oral Tablet

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  2. TAK-935 Tablets

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  3. TAK-951

    Takeda

    Healthy Volunteers

    phase 1 small molecule terminated

    1 trial

  4. TAK-951

    Takeda

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  5. TAK-951

    Takeda

    Nausea and Vomitting

    phase 1 small molecule terminated

    1 trial

  6. TAK-951 Placebo

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  7. TAK-954

    Takeda

    Renal Impairment

    phase 1 small molecule completed

    1 trial

  8. TAK-954

    Takeda

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  9. TAK-954

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  10. TAK-954

    Takeda

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  11. TAK-981

    Takeda

    Head and Neck Cancer

    phase 1 small molecule completed

    1 trial

  12. TAK-988

    Takeda

    Healthy Volunteers

    phase 1 small molecule terminated

    1 trial

  13. TAK-994

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  14. TAK-994

    Takeda

    Healthy Participants

    phase 1 small molecule completed

    2 trials

  15. TAK-994 Oral Tablet

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  16. TAKC-02

    Takeda

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  17. TALEN

    The First People's Hospital of Lianyungang

    Human Papillomavirus-Related Malignant Neoplasm

    phase 1 mab active

    1 trial

  18. TBA-354

    BRIGHT MINDS BIOSCIENCES INC.

    Tuberculosis

    phase 1 small molecule completed

    2 trials

  19. TBA-7371

    BRIGHT MINDS BIOSCIENCES INC.

    Tuberculosis

    phase 1 small molecule completed

    1 trial

  20. TBAJ-587

    BRIGHT MINDS BIOSCIENCES INC.

    Tuberculosis

    phase 1 small molecule completed

    1 trial

  21. TBAJ-876

    BRIGHT MINDS BIOSCIENCES INC.

    Pulmonary Disease

    phase 1 small molecule completed

    1 trial

  22. TBP-PI-HBr

    Spero Therapeutics

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  23. TBP-PI-HBr

    Spero Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  24. TBPM-PI-HBr

    Spero Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    3 trials

  25. TBio-6517

    Takeda

    Solid Tumor

    phase 1 mab terminated

    1 trial

  26. TCR-T cells

    The First People's Hospital of Lianyungang

    Recurrent Hepatocellular Carcinoma

    phase 1 mab active

    1 trial

  27. TD-0714

    Theravance Biopharma Ireland Umited

    Healthy

    phase 1 small molecule completed

    1 trial

  28. TD-0714

    Theravance Biopharma Ireland Umited

    Healthy Adults, Elderly Subjects

    phase 1 small molecule completed

    1 trial

  29. TD-1058

    Theravance Biopharma Ireland Umited

    Idiopathic Pulmonary Fibrosis (IPF)

    phase 1 small molecule terminated

    1 trial

  30. TD-1211 Dose 1

    Theravance Biopharma Ireland Umited

    Constipation

    phase 1 small molecule completed

    1 trial

  31. TD-1439

    Theravance Biopharma Ireland Umited

    Healthy Subjects

    phase 1 small molecule completed

    1 trial

  32. TD-1439

    Theravance Biopharma Ireland Umited

    Healthy Adults, Elderly Subjects

    phase 1 small molecule completed

    1 trial

  33. TD-1473

    Theravance Biopharma Ireland Umited

    Inflammatory Bowel Disease

    phase 1 small molecule completed

    1 trial

  34. TD-1473

    Theravance Biopharma Ireland Umited

    Ulcerative Colitis, Active Moderate

    phase 1 small molecule completed

    1 trial

  35. TD-1473 - Dose A

    Theravance Biopharma Ireland Umited

    Inflammatory Bowel Diseases

    phase 1 small molecule completed

    1 trial

  36. TD-1473 [Tablet A]

    Theravance Biopharma Ireland Umited

    Intestinal Disorder

    phase 1 small molecule completed

    1 trial

  37. TD-1473 for SAD

    Theravance Biopharma Ireland Umited

    Healthy

    phase 1 small molecule completed

    1 trial

  38. TD-1473 oral capsule

    Theravance Biopharma Ireland Umited

    Intestinal Disorders

    phase 1 small molecule completed

    1 trial

  39. TD-1607

    Theravance Biopharma Ireland Umited

    Infections

    phase 1 small molecule completed

    1 trial

  40. TD-1607

    Theravance Biopharma Ireland Umited

    Serious Infections Due to Known or Suspected Gram-positive Pathogens

    phase 1 small molecule completed

    1 trial

  41. TD-3504

    Theravance Biopharma Ireland Umited

    Active Mild Ulcerative Colitis, Active Moderate Ulcerative Colitis, Healthy Subjects

    phase 1 small molecule completed

    1 trial

  42. TD-4208

    Theravance Biopharma Ireland Umited

    Renal Impairment

    phase 1 small molecule completed

    1 trial

  43. TD-4208

    Theravance Biopharma Ireland Umited

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  44. TD-4208 175 mcg

    Theravance Biopharma Ireland Umited

    Cardiac Repolarization in Healthy Subjects

    phase 1 small molecule completed

    1 trial

  45. TD-5202

    Theravance Biopharma Ireland Umited

    Healthy

    phase 1 small molecule completed

    1 trial

  46. TD-6450

    Theravance Biopharma Ireland Umited

    Hepatitis C

    phase 1 small molecule completed

    2 trials

  47. TD-8954

    Theravance Biopharma Ireland Umited

    Gastrointestinal Motility Disorder

    phase 1 small molecule terminated

    1 trial

  48. TD-9855

    Theravance Biopharma Ireland Umited

    ADHD

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many Phase I pipeline programs are in the directory?

4,713 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.